Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin

Citation
Ma. Cohen et Md. Huband, Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin, DIAG MICR I, 33(1), 1999, pp. 43-46
Citations number
22
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Microbiology
Journal title
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
ISSN journal
07328893 → ACNP
Volume
33
Issue
1
Year of publication
1999
Pages
43 - 46
Database
ISI
SICI code
0732-8893(199901)33:1<43:AOCTQA>2.0.ZU;2-C
Abstract
Isolations of Staphylococcus aureus strains with reduced susceptibility to vancomycin are now being reported worldwide. In testing here by broth micro dilution according to NCCLS guidelines and applying vancomycin breakpoint c riteria (susceptible at 4 mu g/mL), two of three strains were susceptible ( MICs at 4 mu g/mL) rather than intermediate (MICs at 8 mu g/mL) as previous ly reported by other laboratories. Clinafloxacin was more active (MICs/MBCs at 0.5 to 2 mu g/mL) than ciprofloxacin, grepafloxacin, levofloxacin, oflo xacin, and sparfloxacin. Trovafloxacin, trimethoprim/sulfamethoxazole, and quinupristin/dalfopristin were the next most active agents, although quinup ristin/dalfopristin was bactericidal against only two of these three strain s. Amikacin, imipenem, oxacillin, and rifampin were less active. (C) 1999 E lsevier Science Inc.